BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7566177)

  • 1. Defective activation and survival of T cells lacking the Ets-1 transcription factor.
    Muthusamy N; Barton K; Leiden JM
    Nature; 1995 Oct; 377(6550):639-42. PubMed ID: 7566177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene.
    Bories JC; Willerford DM; Grévin D; Davidson L; Camus A; Martin P; Stéhelin D; Alt FW
    Nature; 1995 Oct; 377(6550):635-8. PubMed ID: 7566176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus.
    Eyquem S; Chemin K; Fasseu M; Bories JC
    Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15712-7. PubMed ID: 15496469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ets genes in mouse thymocyte subsets and T cells.
    Bhat NK; Komschlies KL; Fujiwara S; Fisher RJ; Mathieson BJ; Gregorio TA; Young HA; Kasik JW; Ozato K; Papas TS
    J Immunol; 1989 Jan; 142(2):672-8. PubMed ID: 2536061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
    Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
    Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factor.
    Eyquem S; Chemin K; Fasseu M; Chopin M; Sigaux F; Cumano A; Bories JC
    Eur J Immunol; 2004 Nov; 34(11):3187-96. PubMed ID: 15384043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models in the study of the Ets family of transcription factors.
    Bartel FO; Higuchi T; Spyropoulos DD
    Oncogene; 2000 Dec; 19(55):6443-54. PubMed ID: 11175360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Neuregulin and autocrine mediated survival of Schwann cells requires activity of Ets family transcription factors.
    Parkinson DB; Langner K; Namini SS; Jessen KR; Mirsky R
    Mol Cell Neurosci; 2002 May; 20(1):154-67. PubMed ID: 12056846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes.
    Fischer KD; Zmuldzinas A; Gardner S; Barbacid M; Bernstein A; Guidos C
    Nature; 1995 Mar; 374(6521):474-7. PubMed ID: 7700360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.
    Su GH; Chen HM; Muthusamy N; Garrett-Sinha LA; Baunoch D; Tenen DG; Simon MC
    EMBO J; 1997 Dec; 16(23):7118-29. PubMed ID: 9384589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.
    Maroulakou IG; Papas TS; Green JE
    Oncogene; 1994 Jun; 9(6):1551-65. PubMed ID: 8183549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene.
    Zhang R; Alt FW; Davidson L; Orkin SH; Swat W
    Nature; 1995 Mar; 374(6521):470-3. PubMed ID: 7700359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor GATA-3 is required for development of the T-cell lineage.
    Ting CN; Olson MC; Barton KP; Leiden JM
    Nature; 1996 Dec; 384(6608):474-8. PubMed ID: 8945476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains.
    Kim WY; Sieweke M; Ogawa E; Wee HJ; Englmeier U; Graf T; Ito Y
    EMBO J; 1999 Mar; 18(6):1609-20. PubMed ID: 10075931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional repressor Gfi1 affects development of early, uncommitted c-Kit+ T cell progenitors and CD4/CD8 lineage decision in the thymus.
    Yücel R; Karsunky H; Klein-Hitpass L; Möröy T
    J Exp Med; 2003 Apr; 197(7):831-44. PubMed ID: 12682108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.